Case Evaluation
Over $150 Million Collected for Plantiffs in 2011


Pradaxa was approved by the EMA (European Medicines Agency) on March 18, 2008 and by the FDA on October 19, 2010.

Since then, hundreds of thousand of patients suffering from atrial fibrillation have been prescribed this anticoagulant drug to help prevent blood clots and strokes.

However, there have been hundreds of serious and even fatal Pradaxa bleeding episodes. The FDA has received over 500 reports of serious injury and or death, due to patients taking Pradaxa and has announced that they will launch an investigation into the safety of the drug.

These reports indicate that internal bleeding caused from taking Pradaxa may include:

  • Hemorrhaging of kidneys
  • Hemorrhaging of the brain
  • Hemorrhaging of gastrointestinal organs

Due to the neglectfulness of the drug manufacturer to warn of the risk of massive internal bleeding that can be associated with taking this drug, they are liable for the damages that have been suffered by the patients and their families.

There are qualified attorneys helping those that have been affected by Pradaxa bleeding file a claim for their loss.

If you or someone you love has suffered Pradaxa bleeding, an injury or death from taking this drug, it is imperative that you speak to an attorney as soon as possible. There may be substantial financial compensation available to you, but, YOU must act now, time is limited.

A qualified attorney will be able to explain to you how Boehringer Ingelheim, the Pradaxa drug maker may have known that taking the drug could cause serious and or fatal internal bleeding.

However, they continued to market the drug regardless of the potential catastrophic consequences.

In just the first three months of 2011 alone, the FDA received over 500 allegations of serious injuries and even death from massive internal bleeding from patients who had been prescribed the anticoagulant drug Pradaxa.

There are experts that believe the company had previous knowledge of the risks associated with using Pradaxa during the clinical trials but failed to disclose them in time to save patients.

Other blood thinning drugs like Warfarin and Coumadin also carry a risk of internal bleeding, however, the side effects can be treated with vitamin K injections by doctors in emergency situations.

In a March 6, 2012 there was a report in the Journal of Neurosurgery which indicated that once Pradaxa causes internal bleeding in a patient, there is very little that doctors can do to stop it.

There have been thousands of lawsuits filed by attorneys with the Pradaxa Litigation Group on behalf of patients and families who were prescribed defective drugs. 

These same lawyers who have recovered millions of dollars for their clients are available to talk to you today about a Pradaxa case.

In order to ensure that your case is handled properly, the Pradaxa Center only works with the top defective drug law firms in the country. Call us today to learn more about the health risks associated with Pradaxa. We are here to answer your questions and provide you with help, 24/7.



Pradaxa Quick Links


Facebook Twitter Youtube